SEP 27, 2019 8:37 AM PDT

AI Exponentially Accelerates Drug Development

WRITTEN BY: Annie Lennon

Research and development for new drugs is both an expensive and lengthy process, often lasting years, if not decades. With the development of artificial intelligence technology however, this process is both becoming more cost-efficient and shorter, something that is expected to exponentially accelerate the development of new drugs. 

According to Brendan Frey, founder and CEO of AI-based drug discovery company, Deep Genomics, developing drugs has traditionally been like gambling, “It’s like the Big Pharma companies come into a casino, put a million-dollar coin into a slot machine and with some probability like 10% or something, they get a win (Robertson: 2019).”

This is where AI comes in. Until now, Deep Genomics has developed over 20 machine learning systems trained from both public and proprietary data to screen for disease-causing mutations while looking for drug targets. In just two hours, their technology can screen over 200,000 pathogenic mutations and automatically suggest potential drug targets.

Frey said, “I am certain that we are witnessing a new era of drug discovery… Our AI systems can figure out how diseases are caused and how to fix those diseases much more rapidly than humans ever could and also with a greater success rate (ibid.).”

In particular, Frey and his team have used their machine learning systems to find potential drugs for Wilson's disease, a rare genetic disorder that leads to excessive build-up of copper in various body tissues. If left untreated, it can cause liver disease and central nervous system dysfunction, ultimately leading to death (Rare Disease Database: 2019). Although current drugs m to reduce copper levels in the body by stopping their absorption from food, no treatments have yet been made to restore the body’s natural ability to remove the metal. 

Using Deep Genomics AI however, Frey and his team were both able to understand how a mutation changes an amino acid in a copper-binding protein, an identify 24 potential new drug candidates. After testing these further, they were then able to announce a candidate for further development as an investigational new drug (Philippidis: 2019). 

With such a process usually taking around 17 years now possible in just 18 months, Frederick Askari, the Director of the Wilson Disease Program at the University of Michigan said: ”The clarity that this artificial intelligence platform has brought to the scientific community is astounding and the potential of a therapy that could operate at the genomic level to correct the disease process is exciting.”


 

Sources

 

Roberston, Sally: News Medical 

Rare Disease Database: National Organization for Rare Disorders 

Philippidis, Alex: Genetic Engineering and Biotechnology News

About the Author
  • Science writer with a keen interest in behavioral biology, consciousness medicine and technology. Her current focus is how the interplay of these fields can create meaningful interactions, products and environments.
You May Also Like
FEB 26, 2021
Microbiology
Good Bacteria Fights Bad Bacteria in a Clinical Trial
FEB 26, 2021
Good Bacteria Fights Bad Bacteria in a Clinical Trial
Eczema is a skin condition that causes a chronic, itchy rash. The most common form of the disorder, atopic dermatitis, i ...
APR 03, 2021
Drug Discovery & Development
Why Are Some Cancer Therapeutics Ineffective?
APR 03, 2021
Why Are Some Cancer Therapeutics Ineffective?
Why don’t some cancer therapeutics not work in humans when they were successful in mice? The answer to this questi ...
APR 14, 2021
Cancer
Cell Viability- Where to Begin?
APR 14, 2021
Cell Viability- Where to Begin?
Written By: Author As I pondered the title of this article, my thoughts immediately went back to a request by my Ph.D. a ...
APR 07, 2021
Drug Discovery & Development
Therapeutics Enhance The Body's Natural Killers
APR 07, 2021
Therapeutics Enhance The Body's Natural Killers
Most people who have been prescribed pain killers are familiar with fentanyl, oxycodone, and morphine. These substances ...
APR 27, 2021
Drug Discovery & Development
Natural Remedy Better than Steroids For COVID-19 Smell Loss
APR 27, 2021
Natural Remedy Better than Steroids For COVID-19 Smell Loss
An international group of olfactory experts have recommended against the use of steroid treatments for loss of smell rel ...
JUN 02, 2021
Cannabis Sciences
Can CBD Help Manage Symptoms of Diabetes?
JUN 02, 2021
Can CBD Help Manage Symptoms of Diabetes?
As cannabidiol (CBD) products become increasingly mainstream, more people are using them to manage symptoms for chronic ...
Loading Comments...